These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 26229697)

  • 21. [Acanthosis nigricans, hyperandrogenism, insulin resistance and mixed hyperlipemia].
    Thivolet CH; Mauduit G; Canivet B; Garrel D; Tourniaire J; Thivolet J; Pugeat M
    Presse Med; 1988 Jul; 17(26):1355-9. PubMed ID: 2970081
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of obesity and hyperinsulinemia in the insulin resistance of obese subjects with the clinical triad of polycystic ovaries, hirsutism and acanthosis nigricans.
    Wajchenberg BL; Giannella-Neto D; Lerario AC; Marcondes JA; Ohnuma LY
    Horm Res; 1988; 29(1):7-13. PubMed ID: 3397043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel insulin receptor mutation in an adolescent with acanthosis nigricans and hyperandrogenism.
    Krishnamurthy M; Pingul MM
    J Pediatr Endocrinol Metab; 2016 Oct; 29(10):1201-1205. PubMed ID: 27505086
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An adolescent girl with coexisting ovarian mature cystic teratoma and HAIR-AN syndrome, an extreme subtype of polycystic ovarian syndrome.
    Ho JH; Abd Wahab AV; Fung YK; Khoo SSK
    Endocrinol Diabetes Metab Case Rep; 2021 Feb; 2021():. PubMed ID: 33597313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acne as a chronic systemic disease.
    Zouboulis CC
    Clin Dermatol; 2014; 32(3):389-96. PubMed ID: 24767186
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Androgen excess disorders in women: the severe insulin-resistant hyperandrogenic syndrome, HAIR-AN.
    Rager KM; Omar HA
    ScientificWorldJournal; 2006 Jan; 6():116-21. PubMed ID: 16435040
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GnRH Agonist Improves Hyperandrogenism in an Adolescent Girl With an Insulin Receptor Gene Mutation.
    Paprocki E; Barral RL; Vanden Brink H; Lujan M; Burgert TS
    J Endocr Soc; 2019 Jun; 3(6):1196-1200. PubMed ID: 31187077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hyperandrogenism, adrenal dysfunction, and hirsutism].
    Makrantonaki E; Zouboulis CC
    Hautarzt; 2020 Oct; 71(10):752-761. PubMed ID: 32857168
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Exploration of the classification of polycystic ovarian syndrome].
    Lin JF; Li X; Zhu MW
    Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):684-8. PubMed ID: 17199924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Severe hyperandrogenism due to ovarian hyperthecosis in a young woman.
    Goyal A; Malhotra R; Kulshrestha V; Kachhawa G
    BMJ Case Rep; 2019 Dec; 12(12):. PubMed ID: 31852694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biliopancreatic diversion as a novel approach to the HAIR-AN syndrome.
    Manco M; Castagneto M; Nanni G; Guidone C; Tondolo V; Greco AV; Gasbarrini G; Mingrone G
    Obes Surg; 2005 Feb; 15(2):286-9. PubMed ID: 15802076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
    Hassa H; Tanir HM; Yildiz Z
    Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of dermatologic manifestations and metabolic biomarkers in women with polycystic ovary syndrome in north China.
    Feng JG; Guo Y; Ma LA; Xing J; Sun RF; Zhu W
    J Cosmet Dermatol; 2018 Jun; 17(3):511-517. PubMed ID: 28940857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [HAIR-AN syndrome].
    Kadowaki H; Kadowaki T
    Nihon Rinsho; 1994 Oct; 52(10):2648-52. PubMed ID: 7983793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Study on the facial and body terminal hair growth in women in Guangdong by using modified Ferriman-Gallwey scoring system].
    Zhao XM; Ni RM; Huang J; Huang LL; Du SM; Ma MJ; Lin DY; Yang DZ
    Zhonghua Fu Chan Ke Za Zhi; 2013 Jun; 48(6):427-31. PubMed ID: 24103121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical course of genetic diseases of the insulin receptor (type A and Rabson-Mendenhall syndromes): a 30-year prospective.
    Musso C; Cochran E; Moran SA; Skarulis MC; Oral EA; Taylor S; Gorden P
    Medicine (Baltimore); 2004 Jul; 83(4):209-222. PubMed ID: 15232309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non polycystic ovary syndrome-related endocrine disorders associated with hirsutism.
    Unluhizarci K; Kaltsas G; Kelestimur F
    Eur J Clin Invest; 2012 Jan; 42(1):86-94. PubMed ID: 21623779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acanthosis nigricans, insulin resistance and cutaneous virilism.
    Barth JH; Ng LL; Wojnarowska F; Dawber RP
    Br J Dermatol; 1988 May; 118(5):613-9. PubMed ID: 3293647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of Successive Pharmacologic Hormone Suppression Testing for a Severe Presentation of Adolescent Polycystic Ovarian Syndrome: A Case Report.
    Ravi SJ; Cree-Green M
    J Investig Med High Impact Case Rep; 2019; 7():2324709619850215. PubMed ID: 31113263
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical, biochemical, and ovarian morphologic features in women with acanthosis nigricans and masculinization.
    Dunaif A; Hoffman AR; Scully RE; Flier JS; Longcope C; Levy LJ; Crowley WF
    Obstet Gynecol; 1985 Oct; 66(4):545-52. PubMed ID: 3900841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.